| scholarly article | Q13442814 |
| P50 | author | Per Svenningsson | Q21175215 |
| Paul Greengard | Q309979 | ||
| Gaute T. Einevoll | Q11971645 | ||
| Ole A. Andreassen | Q31229142 | ||
| Srdjan Djurovic | Q34568432 | ||
| Tuomo Mäki-Marttunen | Q41046042 | ||
| Olav B Smeland | Q57081237 | ||
| Anders M. Dale | Q57693390 | ||
| P2093 | author name string | Y Wang | |
| D Holland | |||
| C-H Chen | |||
| R S Desikan | |||
| L K McEvoy | |||
| A J Schork | |||
| W K Thompson | |||
| C-C Fan | |||
| A Devor | |||
| A Witoelar | |||
| P2860 | cites work | Rethinking schizophrenia | Q22251086 |
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis | Q24597718 | ||
| GABAergic interneuron origin of schizophrenia pathophysiology. | Q24597790 | ||
| Five years of GWAS discovery | Q24610574 | ||
| D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor | Q24675924 | ||
| The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia | Q24798030 | ||
| Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology | Q27013601 | ||
| Optogenetic pharmacology for control of native neuronal signaling proteins | Q27015715 | ||
| Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits | Q28071885 | ||
| Heritability estimates for psychotic disorders: the Maudsley twin psychosis series | Q28137629 | ||
| Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex | Q28138248 | ||
| Genome-wide association study identifies five new schizophrenia loci | Q28248384 | ||
| DISC1 at 10: connecting psychiatric genetics and neuroscience | Q28250914 | ||
| Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia | Q28262977 | ||
| Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 | ||
| The physiology, signaling, and pharmacology of dopamine receptors | Q28305030 | ||
| Pleiotropy in complex traits: challenges and strategies | Q28390545 | ||
| A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions | Q28643908 | ||
| Calcium signalling: dynamics, homeostasis and remodelling | Q29547635 | ||
| Spatio-temporal transcriptome of the human brain | Q29614572 | ||
| Functional Effects of Schizophrenia-Linked Genetic Variants on Intrinsic Single-Neuron Excitability: A Modeling Study. | Q30366617 | ||
| Pervasive sharing of genetic effects in autoimmune disease | Q30431030 | ||
| Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders | Q30469044 | ||
| N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? | Q30474021 | ||
| The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave | Q30615326 | ||
| New statistical approaches exploit the polygenic architecture of schizophrenia--implications for the underlying neurobiology | Q30844089 | ||
| Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder | Q33470869 | ||
| Shared common variants in prostate cancer and blood lipids | Q34001263 | ||
| A polygenic burden of rare disruptive mutations in schizophrenia | Q34060200 | ||
| The neurobiology of slow synaptic transmission | Q34100272 | ||
| Linking neurodevelopmental and synaptic theories of mental illness through DISC1 | Q34233683 | ||
| Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse | Q34321656 | ||
| Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors | Q34325802 | ||
| Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate | Q34342469 | ||
| The Psychiatric GWAS Consortium: Big Science Comes to Psychiatry | Q34350128 | ||
| Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors | Q34498817 | ||
| De novo mutations in schizophrenia implicate synaptic networks | Q34540372 | ||
| Computational psychiatry. | Q34630298 | ||
| From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment | Q34632695 | ||
| Modeling human cortical development in vitro using induced pluripotent stem cells | Q34639912 | ||
| All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs | Q34699776 | ||
| The intense world syndrome--an alternative hypothesis for autism | Q34871941 | ||
| Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci | Q35168836 | ||
| Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways | Q35230796 | ||
| Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32 | Q35356825 | ||
| Abundant pleiotropy in human complex diseases and traits. | Q35542127 | ||
| DARPP-32: an integrator of neurotransmission | Q35639141 | ||
| Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture | Q35811877 | ||
| Leveraging Genomic Annotations and Pleiotropic Enrichment for Improved Replication Rates in Schizophrenia GWAS. | Q35903759 | ||
| Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid | Q35941298 | ||
| Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus | Q35963497 | ||
| Optical electrophysiology for probing function and pharmacology of voltage-gated ion channels | Q36027162 | ||
| Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. | Q36253911 | ||
| From antipsychotic to anti-schizophrenia drugs: role of animal models | Q36287726 | ||
| Statistical connectivity provides a sufficient foundation for specific functional connectivity in neocortical neural microcircuits | Q36342487 | ||
| Regulation of Ca(V)2 calcium channels by G protein coupled receptors. | Q36565441 | ||
| DREADDs for Neuroscientists | Q36595793 | ||
| Electrical activity in early neuronal development | Q36676053 | ||
| Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders | Q36707022 | ||
| Pathway analysis of seven common diseases assessed by genome-wide association | Q37014849 | ||
| The challenge of connecting the dots in the B.R.A.I.N. | Q37395958 | ||
| The pleiotropic structure of the genotype-phenotype map: the evolvability of complex organisms. | Q37844408 | ||
| Calcium signalling remodelling and disease | Q37995715 | ||
| Structure and function of the β subunit of voltage-gated Ca²⁺ channels | Q38043712 | ||
| Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells | Q38170728 | ||
| Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia | Q38191819 | ||
| Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next | Q38559394 | ||
| Optical sensors to gain mechanistic insights into signaling assemblies | Q38950115 | ||
| Genome-Editing Technologies: Principles and Applications | Q39026438 | ||
| A biophysically detailed model of neocortical local field potentials predicts the critical role of active membrane currents | Q39377429 | ||
| A cellular mechanism for cortical associations: an organizing principle for the cerebral cortex | Q39494445 | ||
| Reconstruction and Simulation of Neocortical Microcircuitry. | Q40320870 | ||
| The computational anatomy of psychosis | Q41199035 | ||
| Application of cDNA microarrays to examine gene expression differences in schizophrenia | Q43750661 | ||
| Identification of Gene Loci That Overlap Between Schizophrenia and Educational Attainment | Q46090041 | ||
| Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid | Q48101402 | ||
| Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo | Q48170047 | ||
| Behavioral phenotypes of Disc1 missense mutations in mice | Q48178658 | ||
| Hybrid Scheme for Modeling Local Field Potentials from Point-Neuron Networks | Q48449712 | ||
| Schizophrenia | Q55868331 | ||
| Delineating novel signature patterns of altered gene expression in schizophrenia using gene microarrays. | Q64905908 | ||
| The human genome: gene expression profiling and schizophrenia | Q74453170 | ||
| Calcium signaling dysfunction in schizophrenia: a unifying approach | Q79073580 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 792-801 | |
| P577 | publication date | 2017-03-28 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia | |
| P478 | volume | 22 |
| Q98166913 | A unified computational model for cortical post-synaptic plasticity |
| Q60949982 | Alterations in Schizophrenia-Associated Genes Can Lead to Increased Power in Delta Oscillations |
| Q64102599 | Attenuation of Novelty-Induced Hyperactivity of Mice by Cannabidiol and Hippocampal Inhibitory Chemogenetics |
| Q92799609 | Biophysical Psychiatry-How Computational Neuroscience Can Help to Understand the Complex Mechanisms of Mental Disorders |
| Q64945067 | Brain function, structure and genomic data are linked but show different sensitivity to duration of illness and disease stage in schizophrenia. |
| Q90732283 | Computational Modeling of Genetic Contributions to Excitability and Neural Coding in Layer V Pyramidal Cells: Applications to Schizophrenia Pathology |
| Q55180784 | Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder. |
| Q90172402 | Deconvolution of transcriptional networks identifies TCF4 as a master regulator in schizophrenia |
| Q52316128 | Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder. |
| Q56888533 | Genetic variation in 117 myelination-related genes in schizophrenia: Replication of association to lipid biosynthesis genes |
| Q60460217 | Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence |
| Q38659979 | Identification of Genetic Loci Jointly Influencing Schizophrenia Risk and the Cognitive Traits of Verbal-Numerical Reasoning, Reaction Time, and General Cognitive Function |
| Q92595950 | Integrating genome-wide association study with regulatory SNP annotation information identified candidate genes and pathways for schizophrenia |
| Q50317783 | Pleiotropic effects of schizophrenia-associated genetic variants in neuron firing and cardiac pacemaking revealed by computational modeling. |
| Q47557531 | Psychiatric genetics and the structure of psychopathology. |
| Q46194843 | The Thymus/Neocortex Hypothesis of the Brain: A Cell Basis for Recognition and Instruction of Self. |
| Q96302720 | The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology |
| Q90666112 | Use of tobacco in schizophrenia: A double-edged sword |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.